Therabest USA is a discovery/preclinical-stage biotech company. Our focus is the development of immunotherapy in the setting of allogeneic adoptive transfer and biologics that improve well-being.
Our programs include Off-the-Shelf production of immune cells for universal cell therapy products as well as precision biologics. We educate the immune system to target/attack specific abnormal cells as well as to enhance the immune response to eliminate hematological and solid cancer.
Our research focuses on the development of the efficient manufacturing processes of safe, effective off-the-shelf immune cells for universal application in immunotherapy.
Our team, consisting of a group of professionals that work in regenerative medicine, cell manufacturing, and cancer immunotherapy, is enthusiastic about the collaborative effort on development of the cutting-edge precision science to translational medicine.
In addition to our focused therapeutic area, we provide customers with analytical method development and immunotherapy R&D services.
Company Details
- Founded
- -
- Address
- 9276 Scranton Rd,
- Industry
- Biotechnology
- Website
- http://therabest.co.kr/en/
- Keywords
- Hannam University.
- HQ
- San Diego, California
Therabest Usa Questions
Therabest Usa's website is http://therabest.co.kr/en/
Therabest Usa's LinkedIn profile is https://www.linkedin.com/company/therabest-usa
Therabest Usa's industry is
Biotechnology
Therabest Usa's top competitors are
Hannam University Graduate School,
Pulsebio Consulting,
Hannam University (한남대학교),
Motimac Usa,
Jw Froehlich Usa,
Therabest,
Lillbacka Usa,
Korean Tech Initiative,
Hannam University,
Esband Usa.
Therabest Usa's categories are Biotechnology
Therabest Usa's founding year is 2021
